JY
IPCI

Jeff Yass’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Jeff Yass’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,550
Closed -$7K – 10782
2018
Q2 		$7K Buy
+1,550
New +$7.04K ﹤0.01% 9477
2018
Q1 		– Sell
-4,614
Closed -$37K – 10691
2017
Q4 		$37K Buy
4,614
+758
+20% +$6.89K ﹤0.01% 8991
2017
Q3 		$38K Sell
3,856
-10,554
-73% -$151K ﹤0.01% 8589
2017
Q2 		$301K Buy
14,410
+11,291
+362% +$237K ﹤0.01% 7594
2017
Q1 		$79K Sell
3,119
-4,598
-60% -$119K ﹤0.01% 8479
2016
Q4 		$219K Buy
7,717
+3,514
+84% +$98.2K ﹤0.01% 8522
2016
Q3 		$89K Buy
+4,203
New +$75.4K ﹤0.01% 7983
2016
Q2 		– Sell
-3,747
Closed -$77K – 9737
2016
Q1 		$77K Sell
3,747
-4,380
-54% -$97.4K ﹤0.01% 8532
2015
Q4 		$166K Sell
8,127
-103
-1% -$2K ﹤0.01% 8572
2015
Q3 		$150K Buy
8,230
+4,705
+133% +$124K ﹤0.01% 8922
2015
Q2 		$104K Buy
+3,525
New +$107K ﹤0.01% 9652
2015
Q1 		– Sell
-3,310
Closed -$80.3K – 10229
2014
Q4 		$75K Sell
3,310
-903
-21% -$24.4K ﹤0.01% 9271
2014
Q3 		$127K Buy
4,213
+2,198
+109% +$63.4K ﹤0.01% 8985
2014
Q2 		$77K Buy
+2,015
New +$77.6K ﹤0.01% 9506

Other funds holding IPCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Jeff Yass's IPCI Position: Q3 2018 in Review

Jeff Yass sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1,550 shares — an estimated $7K sold.

Jeff Yass first reported a position in IPCI in Q2 2014 and held it in 14 quarters. The position peaked at $301K in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Jeff Yass reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Jeff Yass sold 1,550 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $7K.
  • Jeff Yass first reported a position in Intellipharmaceuticals International Inc. in Q2 2014 and held it in 14 quarters.
  • Jeff Yass's Intellipharmaceuticals International Inc. position peaked at $301K in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.